Detalhe da pesquisa
1.
Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer.
J Transl Med
; 21(1): 75, 2023 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36737752
2.
The impact of proton-pump inhibitors administered with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma.
Anticancer Drugs
; 34(1): 178-186, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36539370
3.
Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a).
Int J Mol Sci
; 24(2)2023 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36674615
4.
Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: post-hoc analysis of the Meet-URO 15 study.
Front Oncol
; 14: 1307635, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38410103
5.
Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes.
J Immunother Cancer
; 12(3)2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38448038
6.
The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study.
Ther Adv Urol
; 15: 17562872231187216, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37492625
7.
Clinical outcomes of volume of disease on patients receiving enzalutamide versus abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer.
Ther Adv Med Oncol
; 15: 17588359231156147, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36895852
8.
Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome?
Expert Rev Anticancer Ther
; 23(5): 545-554, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37017710
9.
Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic Score.
Front Biosci (Elite Ed)
; 15(3): 20, 2023 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37743233
10.
Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab.
JAMA Netw Open
; 6(11): e2345185, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38010650
11.
Effects of a Nutritional Supplement (DìRelaxTM) on Anxiety in Dogs in a Randomized Control Trial Design.
Animals (Basel)
; 12(4)2022 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35203143